Theravance Biopharma, Inc. (TBPH)
TBPH · Pharmaceutical Preparations · George Town, Grand Cayman, CA · filing with the SEC since 2013
Grade6.3
◀ Past 5.6● Present 7.4▶ Future 5.4
Filings
342 filings since 2017 beside 543 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.
Filings a yearinsider forms included
92999689100716682
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Sep 23, 2026.Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Sep 23, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 23, 2026
8-K items 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
Major agreement signed; Purchase or sale of a business completed; Listing warning from its exchange; Change to shareholders' rights; Change of control; Officer or director change; Charter, bylaw or fiscal-year change; Other event · Current report
Jun 29, 2026
8-K items 1.01, 7.01, 8.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD); Other event · Current report
Jun 28, 2026
Mar 3, 2026
8-K items 2.02, 2.05, 7.01, 9.01
Results released; Exit or restructuring costs; Investor disclosure (Regulation FD) · Current report
40 of 342 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.